Autotransfusion Devices Market Size & Share, by Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, Other Surgeries); Product Type (Autotransfusion Systems, Accessories); End-user (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4459
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Autotransfusion Devices Landscape

top-features-companies
    • ProCell Surgical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BD (Becton, Dickinson and Company)
    • Fresenius SE & Co. KGaA
    • Medtronic
    • Beijing Jingjing Medical Equipment Co., Ltd.
    • Haematonics Corporation
    • LivaNova PLC
    • Zimmer Biomet
    • SARSTEDT AG & Co. KG
    • Gen World Medical Devices

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • ProCell Surgical Inc. announces its first patient blood management device, ProCell. Procell’s Sponge Blood Recovery is the extraction of blood during the surgical process in intraoperative transfusion.

  • Haemnotics Corporation join hands with Epic, a leading company for delivering electronic health record systems, to provide innovative medical solutions and better results for patients.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4459
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery are few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Rising adoption of minimally invasive surgery, increased usage of hemostatic devices for the transfusions and inefficient separating technique of contaminant from the blood are the few factors likely to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are ProCell Surgical Inc., BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product type, end user, and by region.

The cardiovascular surgery is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying